1. Acknowledgement to Referees

   Acknowledgement to Referees Open access 15 November 2017 Pages: 489 - 491

2. Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research

   • Jaden Brandt
   • Christine Leong

   Review Article Open access 01 September 2017 Pages: 493 - 507

3. Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence

   • Luisa Costa
   • Carlo Perricone
   • Francesco Caso

   Review Article Open access 20 October 2017 Pages: 509 - 522

4. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review

   • Ruben R. Ben-Harari
   • Elizabeth Goodwin
   • Julio Casoy

   Systematic Review Open access 06 September 2017 Pages: 523 - 544

   

5. The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro

   • Ashraf Khalil
   • Mark J. Jameson

   Original Research Article Open access 21 August 2017 Pages: 545 - 555

   

6. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s

   • Jennifer J. Kiser
   • Darlene Lu
   • The ACTG A5309s study team

   Original Research Article Open access 05 September 2017 Pages: 557 - 567

   

7. Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines

   • Xi Zhang
   • Simone Hofmann
   • Sophie Sixou

   Original Research Article Open access 06 September 2017 Pages: 569 - 583

   

8. Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

   • Sebastiano Buti
   • Maddalena Donini
   • Rodolfo Passalacqua

   Original Research Article Open access 11 September 2017 Pages: 585 - 596

   

9. Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D₃) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis

   • Richa Pandey
   • Julia B. Zella
   • Daniel W. Coyne

   Original Research Article Open access 13 September 2017 Pages: 597 - 605

   

10. Pharmacokinetic Effects of Antidrug Antibodies Occurring in Healthy Subjects After a Single Dose of Intravenous Infliximab

    • Eli D. Ehrenpreis

    Original Research Article Open access 06 September 2017 Pages: 607 - 613

    

11. Transmucosal Delivery of Nicotine in Combination with Tincture of Benzoin Inhibits Apoptosis

    • Alex Battaglia
    • Thanh Nguyen

    Original Research Article Open access 20 October 2017 Pages: 615 - 621

    

12. Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline

    • Marco D. Huesch

    Original Research Article Open access 22 October 2017 Pages: 623 - 629

    

13. A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events

    • Paul Goldsmith
    • John Affinito
    • Thomas A. Macek

    Original Research Article Open access 04 November 2017 Pages: 631 - 643

    

14. The Adherence Rate Threshold is Drug Specific

    • Melissa E. Stauffer
    • Paul Hutson
    • Alan Morrison

    Original Research Article Open access 26 October 2017 Pages: 645 - 653